Saturday, May 28, 2022 5:01:16 AM
Have we hit Bottom Yet?? ..My Friend Got disgusted and sold all of his $240,000 dollars in BRTX with a loss of $210,000..He is not talking to Me anymore.A Lifelong Best Friend Blames Me and LA for his Loss..He could have sold when it was a penny and went to .047 and made money.I could have sold and made $210,000 in profit but I held because of being stupid and Greedy..costly mistakes..Now Ihave to hold for ?? Years with my 2,000 shares..LOL.but I wont sell.I bought most of my shares at .0022 so im not taking a loss..LA screwed us with a 4000-1 RS.We know that we have to hold/or buy more now at this low pps..and wait till it runs ..2-5 years ? Im holding but I still believe company is going to lead the Stem Cell World to Greatness.IMO $50 in 2 years if both patents are doing great in Clinical trials..Then who knows..I will get a profit someday that I believe 100% to be true.Buying more next month if pps is this low..got to make up on the other end in
NASDAQ..LOL..Happy Memorial Powerstreet and Declaes and All !
NASDAQ..LOL..Happy Memorial Powerstreet and Declaes and All !
Recent BRTX News
- Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) • PR Newswire (US) • 05/27/2026 11:45:00 AM
- Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) • PR Newswire (Canada) • 05/27/2026 11:45:00 AM
- BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data • GlobeNewswire Inc. • 05/26/2026 03:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 07:30:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:37 PM
- BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals • GlobeNewswire Inc. • 05/13/2026 03:00:00 PM
- BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 05/07/2026 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:17:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 08:10:19 PM
- BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform • GlobeNewswire Inc. • 04/30/2026 02:36:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/27/2026 08:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 09:12:57 PM
- BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/20/2026 09:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/13/2026 09:22:23 PM
- BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform • GlobeNewswire Inc. • 04/07/2026 12:15:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/03/2026 06:46:20 PM
- BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/30/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:20:29 PM
- BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/19/2026 12:00:00 PM
- BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 • GlobeNewswire Inc. • 03/05/2026 01:00:00 PM
- BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- BioRestorative secures Australian patent protection for ThermoStem® obesity therapy platform • IH Market News • 02/24/2026 03:14:07 PM
- BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs • GlobeNewswire Inc. • 02/24/2026 01:30:00 PM
